Windtree Therapeutics Inc (NASDAQ: WINT) Is Getting Increasingly Hard To Ignore
Currently, there are 11.05M common shares owned by the public and among those 11.00M shares have been available to trade. The company’s stock has a 5-day price change of -22.28% and -79.18% over the past three months. WINT shares are trading -68.54% year to date (YTD), with the 12-month market performance down to -98.34% lower. […]
Windtree Therapeutics Inc (NASDAQ: WINT): Stock That Needs Special Handling
Currently, there are 11.05M common shares owned by the public and among those 11.00M shares have been available to trade. The company’s stock has a 5-day price change of 12.58% and -76.94% over the past three months. WINT shares are trading -59.52% year to date (YTD), with the 12-month market performance down to -97.81% lower. […]
There Is Clear Momentum For Windtree Therapeutics Inc (NASDAQ: WINT)
Windtree Therapeutics Inc (WINT) concluded trading on Wednesday at a closing price of $0.14, with 5.23 million shares of worth about $0.73 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -98.04% during that period and on January 29, 2025 the price saw a […]
Windtree Therapeutics Inc (WINT) Outlook Starting To Look Brighter?
Windtree Therapeutics Inc (WINT) concluded trading on Thursday at a closing price of $0.20, with 8.99 million shares of worth about $1.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -94.39% during that period and on January 23, 2025 the price saw a […]
Look For Institutional Buying In Windtree Therapeutics Inc (NASDAQ: WINT)
Windtree Therapeutics Inc (WINT) concluded trading on Wednesday at a closing price of $0.24, with 22.41 million shares of worth about $5.38 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -93.45% during that period and on January 15, 2025 the price saw a […]
Look At Analyst Expectations For A Better Read On Windtree Therapeutics Inc (NASDAQ: WINT)
Alyeska Investment Group LP recently announced the acquisition of new stake in Windtree Therapeutics Inc (NASDAQ:WINT). This fresh investment now brings its stake to 2.65% valued currently at $0.15 million. In addition, The Vanguard Group, Inc. raised its holdings by 41640.0 to 41640.0 shares. With over 0.45 million Windtree Therapeutics Inc (WINT) shares trading Friday […]
